NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
TuesdayMar 14, 2017 8:00 pm

PhaseRx, Inc. (NASDAQ: PZRX) Starts Presentation at 29th Annual Roth Conference

PhaseRx (NASDAQ: PZRX) is a biopharmaceutical company that engages in developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. Its initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The company's i-ERT approach is enabled by its proprietary Hybrid mRNA Technology platform and is applicable to various inherited liver diseases. Its product pipeline includes PRX-OTC for Ornithine Transarbamylase deficiency; PRX-ASL for Argininosuccinate Lyase deficiency; and PRX-ASS1 for Argininosuccinatesynthetase…

Continue Reading

TuesdayMar 14, 2017 8:00 pm

Craft Brew Alliance, Inc. (NASDAQ: BREW) Starts Presentation at 29th Annual ROTH Conference

Craft Brew Alliance (NASDAQ: BREW) (“CBA”) is an independent craft brewing company that brews, brands, and brings to market American craft beers. The company’s portfolio combines the power of Kona Brewing Company, a dynamic, fast-growing national craft beer brand, with an expanding stable of strong regional breweries and innovative lifestyle brands, including Appalachian Mountain Brewery, Cisco Brewers, Omission Brewing Co., Redhook Brewery, Square Mile Cider Co. and Widmer Brothers Brewing. CBA nurtures the growth and development of its brands in today’s increasingly competitive beer market through its state-of-the-art brewing and distribution capability, integrated sales and marketing infrastructure, and strong focus…

Continue Reading

TuesdayMar 14, 2017 8:00 pm

Maxwell Technologies, Inc. (NASDAQ: MXWL) Starts Presentation at 29th Annual Roth Conference

Maxwell Technologies (NASDAQ: MXWL) develops, manufactures and markets energy storage and power delivery products worldwide. The company offers ultra-capacitor cells, and multi-cell packs and modules, which provides energy storage and power delivery solutions for applications in various industries, including transportation, automotive, information technology, renewable energy, and industrial electronics. It also offers CONDIS high-voltage capacitors, such as grading and coupling capacitors, and electronic voltage transformers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution, and measurement of high-voltage electrical energy. For more information, visit the company’s website at www.maxwell.com. About NetworkNewsWire…

Continue Reading

TuesdayMar 14, 2017 8:00 pm

Kopin Corp. (NASDAQ: KOPN) Starts Presentation at 29th Annual Roth Conference

Kopin (NASDAQ: KOPN) is a developer and provider of innovative wearable technologies and solutions for integration into head-worn computing and display systems to military, industrial and consumer customers. Kopin’s technology portfolio includes ultra-small displays, optics, speech enhancement technology, system and hands-free control software, low-power ASICs, and ergonomically designed smart headset reference systems. The company’s proprietary components and technology are protected by more than 300 global patents and patents pending. For more information, visit the company’s website at www.kopin.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

InMed Pharmaceuticals, Inc. (IMLFF) Starts Presentation at 29th Annual ROTH Conference

InMed Pharmaceuticals (OTC: IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver. For more information, visit the company’s website at www.inmedpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

Guidance Software, Inc. (NASDAQ: GUID) Starts Presentation at 29th Annual ROTH Conference

Guidance Software (NASDAQ: GUID) provides platforms to keep valuable information safe and secure. The makers of EnCase®, created for forensic security, and EnForce™, an automated cyber risk management platform, Guidance provides a mission-critical foundation of applications that offer deep 360-degree visibility across all endpoints, devices and networks, allowing proactive identification and remediation of threats. From retail to financial institutions, the company’s field-tested and court-proven solutions are deployed on an estimated 33 million endpoints at more than 70 of the Fortune 100 and hundreds of agencies worldwide, from beginning to endpoint. For more information, visit the company’s website at www.guidancesoftware.com. About…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

Polar Power Inc. (NASDAQ: POLA) Starts Presentation at 29th Annual Roth Conference

Polar Power (NASDAQ: POLA) designs, manufactures and sells direct current (DC) power systems for applications in the telecommunications, military, electric vehicle charging, cogeneration, distributed power and uninterruptable power supply markets. It offers DC base power systems, DC hybrid power systems and DC solar hybrid power systems. Polar Power installs, sells and services its products through its direct sales force and a network of independent service providers and dealers. The company was formerly known as Polar Products, Inc. and changed its name to Polar Power, Inc. in October 1991. For more information, visit the company’s website at www.polarpower.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

Titan Medical, Inc. (TMD) Starts Presentation at 29th Annual Roth Conference

Titan Medical (OTC: TMD) is a development-stage company that focuses on the design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing Single Port Orifice Robotic Technology (SPORT) Surgical System, a single-port/single-incision robotic surgical system that comprises a surgeon-controlled robotic platform, which includes a 3D vision system and interactive instruments for performing MIS procedures. Its SPORT Surgical System also includes a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

Naked Brand Group (NASDAQ: NAKD) Starts Presentation at 29th Annual Roth Conference

Naked Brand (NASDAQ: NAKD) designs, manufactures and sells men’s and women’s underwear, intimate apparel, loungewear, and sleepwear products in the United States and Canada. It offers various innerwear products for men, including boxer briefs, trunks, briefs, undershirts, T-shirts, lounge pants, lounge shorts and robes, as well as loungewear and sleepwear products for women, such as boyshorts, hipsters, lounge pants and tops, camisoles, tank tops, pajamas, chemises, sleepshirts, and robes primarily under the Naked brand name. The company sells its products to consumers and retailers through wholesale channels; and direct-to-consumer channel, which consists of an online e-commerce store, wearnaked.com. For more…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

Global Blood Therapeutics, Inc. (NASDAQ: GBT) Starts Presentation at 29th Annual ROTH Conference

Global Blood Therapeutics (NASDAQ: GBT) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. The company is developing its lead product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease. Additionally, the company is investigating GBT440 for the treatment of hypoxemic pulmonary disorders including idiopathic pulmonary fibrosis. For more information, visit the company’s website at www.globalbloodtx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers